PCSK9estäjiä
PCSK9estäjiä, also known as PCSK9 inhibitors, are a class of medications used to lower cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol. They work by targeting a protein called PCSK9. This protein normally binds to LDL receptors on the surface of liver cells and promotes their degradation. By reducing the number of LDL receptors, PCSK9 effectively limits the liver's ability to remove LDL cholesterol from the bloodstream.
PCSK9 inhibitors are typically monoclonal antibodies that bind to PCSK9, preventing it from interacting with LDL
These drugs are generally administered via injection, either subcutaneously or intravenously, and are often prescribed for